HIND — Vyome Holdings Share News
0.000.00%
Last trade - 00:00- $12.56m
- $5.94m
- $0.32m
Brief: ReShape Lifesciences Announces 1-For-25 Reverse Stock Split
Brief: ReShape Lifesciences Reports Year Ended December 31, 2024 Financial Results and Provides Corporate Update
U.S. STOCKS ON THE MOVE-General Mills, Meta Platforms, Domino's Pizza
U.S. STOCKS ON THE MOVE-Watsco, Septerna, Nike
U.S. STOCKS ON THE MOVE-Wynn Resorts, Southwest Airlines, Extreme Networks
ReShape Lifesciences slumps after $6 mln public offering
Brief: Reshape Lifesciences Says Pricing Of Upsized $6.0 Million Public Offering
Brief: Reshape Lifesciences Announces 1-For-58 Reverse Stock Split
Brief: Vyome To Go Public And Trade On Nasdaq Under Ticker Symbol “HIND”
U.S. STOCKS ON THE MOVE-Helios Technologies, Indivior, Principal Financial
ReShape Lifesciences rises on all-stock merger agreement
Brief: ReShape Lifesciences® Enters Into Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys
ReShape Lifesciences Inc reports results for the quarter ended in March - Earnings Summary
Brief: ReShape Lifesciences Q1 Net Income USD -2.193 Million
ReShape Lifesciences Inc expected to post a loss of 16 cents a share - Earnings Preview
Brief: Reshape Lifesciences Files For Shelf Of Up To 11.7 Million Shares Of Common Stock By Selling Stockholder - SEC Filing
Brief: ReShape Lifesciences Receives NASDAQ Notice On Not Regaining Compliance With Minimum Bid Price Requirement
Brief: ReShape Lifesciences Reaffirms Commitment To Profitability
Brief: Reshape Lifesciences Says Co Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq